Streetwise Nutraceuticals Articles


Portfolio Manager's Biotech Watchlist Picks for 2018

  ()
StoneCastle Investment Management has a high-growth fund that invests wherever it finds opportunities, and it is bullish on healthcare. In this interview with The Life Sciences Report, portfolio manager Bruce Campbell highlights four companies that he is putting on Streetwise Reports' 2018 Biotech Watchlist. read more >

Cannabis Cultivator Poised to Profit When Recreational Marijuana Becomes Legal in Canada

Contributed Opinion
  ()
With the Canadian cannabis market primed to be worth billions upon legalization of recreational marijuana use, Lior Gantz of Wealth Research Group makes the case for an "undervalued" competitor. read more >

The ASX: Investing in an Emerging Biotech Frontier

Contributed Opinion
Source: Stuart Roberts for The Life Sciences Report  (08/10/2016)
The ASX: Investing in an Emerging Biotech Frontier
Concerned about investing in the life sciences in the United States, where markets have slumped in 2016 and the presidential election furthers volatility? NDF Research Founder Stuart Roberts makes an argument for taking a look at investment opportunities Down Under. read more >

VANC Pharmaceuticals Could Earn 75% Net Margin with OTC Iron Supplement

Contributed Opinion
Source: Nick Hodge, Outsider Club  (03/28/2016)
VANC Pharmaceuticals Could Earn 75% Net Margin with OTC Iron Supplement
On March 7, VANC Pharmaceuticals announced the launch of a new over-the-counter (OTC) iron supplement called Hema-Fer. As the company gears up to market Hema-Fer across Canada, it is important to understand that VANC sells two types of products: generic prescription drugs and over-the-counter products. read more >

How to Get Your Piece of the Growing $186B Biomarine Industry: BICA's Pierre Erwes

Source: JT Long of The Life Sciences Report  (12/09/2015)
How to Get Your Piece of the Growing $186B Biomarine Industry: BICA's Pierre Erwes
Sustainable harvesting the bounty of the ocean for pharmaceutical, nutritional and cosmetic uses is big business. BioMarine International Clusters Association Chairman Pierre Erwes shares the names of some public and private biotech companies making waves in the blue economy. read more >

Jim Collins: Five Names to Love from the LD Micro Conference

Source: Streetwise Reports' Special Situations Staff  (08/20/2014)
including Jim Collins: Five Names to Love from the LD Micro Conference read more >
Showing Results: 1 to 6 of 6

Get Our Streetwise Reports Life Sciences Report Newsletter Free

A valid email address is required to subscribe

More Experts